aluates Reports

$ 0.0

Automative

Global Non-Invasive Prenatal Screening (NIPS) Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-2C10578

Global Non Invasive Prenatal Screening NIPS Market Research Report 2022

BUY CHAPTERS

Global Non-Invasive Prenatal Screening (NIPS) Market Research Report 2025

Code: QYRE-Auto-2C10578

Report

March 2025

Pages:73

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Myriad Genetics

Illumina Inc

Progenity，Inc

Natera

LabCorp

PerkinElmer Inc

Harmony

Yourgene Health

Roche Sequencing Solutions (RSS)

Eurofins LifeCodexx GmbH

Non-Invasive Prenatal Screening (NIPS) Market Size

The global market for Non-Invasive Prenatal Screening (NIPS) was valued at US$ 4524 million in the year 2024 and is projected to reach a revised size of US$ 8524 million by 2031, growing at a CAGR of 9.6% during the forecast period.

Non-Invasive Prenatal Screening (NIPS) Market

Non-invasive prenatal screening (NIPS) is an emerging prenatal screening technology with many advantages, including non-invasiveness and high accuracy. As technology continues to advance and the market continues to expand, the development prospects of NIPS look very promising.

First, the market demand for NIPS is growing. With the improvement of people"s health awareness and the popularization of the concept of eugenics and postnatal care, more and more pregnant women choose to undergo prenatal screening. Compared with traditional screening methods, NIPS has higher accuracy and wider applicability, so it is increasingly favored by pregnant women. At the same time, with the full liberalization of the two-child policy, the proportion of older mothers has increased significantly, and the demand for NIPS will further increase.

Secondly, NIPS technology is constantly improving. With the rapid development of gene sequencing technology, the detection accuracy and reliability of NIPS continue to improve. For example, second-generation sequencing technology (NGS) has been widely used in NIPS, which can detect multiple gene mutations simultaneously, thereby improving the accuracy and efficiency of detection. In addition, with the development of artificial intelligence and big data technology, NIPS analysis and interpretation have become more accurate and faster.

However, the development of NIPS also faces some challenges. For example, currently NIPS can only detect some common chromosomal diseases and may not provide accurate predictions for other diseases. In addition, the relatively high cost of NIPS also limits its popularity in some areas. At the same time, the supervision of the accuracy and security of NIPS also needs to be further improved.

In general, although the development of NIPS still faces some challenges, with the continuous advancement of technology and the continuous expansion of the market, its development prospects look very promising. In the future, NIPS may become one of the main means of prenatal screening and play an important role in ensuring the health of mothers and infants.

This report aims to provide a comprehensive presentation of the global market for Non-Invasive Prenatal Screening (NIPS), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Invasive Prenatal Screening (NIPS).

The Non-Invasive Prenatal Screening (NIPS) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Non-Invasive Prenatal Screening (NIPS) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Non-Invasive Prenatal Screening (NIPS) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Non-Invasive Prenatal Screening (NIPS) Market Report

Report Metric	Details
Report Name	Non-Invasive Prenatal Screening (NIPS) Market
Accounted market size in year	US$ 4524 million
Forecasted market size in 2031	US$ 8524 million
CAGR	9.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Trisomy 21 Trisomy 18 Trisomy 13 Sex Chromosome Aneuploidies Others
Segment by Application	Hospital Clinic
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Myriad Genetics, Illumina, Progenity, Natera, Yourgene Health, Roche Sequencing Solutions (RSS), Eurofins LifeCodexx GmbH, Labcorp, PerkinElmer, Harmony
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-Invasive Prenatal Screening (NIPS) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Non-Invasive Prenatal Screening (NIPS) Market growing?

Ans: The Non-Invasive Prenatal Screening (NIPS) Market witnessing a CAGR of 9.6% during the forecast period 2025-2031.

What is the Non-Invasive Prenatal Screening (NIPS) Market size in 2031?

Ans: The Non-Invasive Prenatal Screening (NIPS) Market size in 2031 will be US$ 8524 million.

Who are the main players in the Non-Invasive Prenatal Screening (NIPS) Market report?

Ans: The main players in the Non-Invasive Prenatal Screening (NIPS) Market are Myriad Genetics, Illumina, Progenity, Natera, Yourgene Health, Roche Sequencing Solutions (RSS), Eurofins LifeCodexx GmbH, Labcorp, PerkinElmer, Harmony

What are the Application segmentation covered in the Non-Invasive Prenatal Screening (NIPS) Market report?

Ans: The Applications covered in the Non-Invasive Prenatal Screening (NIPS) Market report are Hospital, Clinic

What are the Type segmentation covered in the Non-Invasive Prenatal Screening (NIPS) Market report?

Ans: The Types covered in the Non-Invasive Prenatal Screening (NIPS) Market report are Trisomy 21, Trisomy 18, Trisomy 13, Sex Chromosome Aneuploidies, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Trisomy 21

1.2.3 Trisomy 18

1.2.4 Trisomy 13

1.2.5 Sex Chromosome Aneuploidies

1.2.6 Others

1.3 Market by Application

1.3.1 Global Non-Invasive Prenatal Screening (NIPS) Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Non-Invasive Prenatal Screening (NIPS) Market Perspective (2020-2031)

2.2 Global Non-Invasive Prenatal Screening (NIPS) Growth Trends by Region

2.2.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Non-Invasive Prenatal Screening (NIPS) Historic Market Size by Region (2020-2025)

2.2.3 Non-Invasive Prenatal Screening (NIPS) Forecasted Market Size by Region (2026-2031)

2.3 Non-Invasive Prenatal Screening (NIPS) Market Dynamics

2.3.1 Non-Invasive Prenatal Screening (NIPS) Industry Trends

2.3.2 Non-Invasive Prenatal Screening (NIPS) Market Drivers

2.3.3 Non-Invasive Prenatal Screening (NIPS) Market Challenges

2.3.4 Non-Invasive Prenatal Screening (NIPS) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Non-Invasive Prenatal Screening (NIPS) Players by Revenue

3.1.1 Global Top Non-Invasive Prenatal Screening (NIPS) Players by Revenue (2020-2025)

3.1.2 Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Players (2020-2025)

3.2 Global Non-Invasive Prenatal Screening (NIPS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Non-Invasive Prenatal Screening (NIPS) Revenue

3.4 Global Non-Invasive Prenatal Screening (NIPS) Market Concentration Ratio

3.4.1 Global Non-Invasive Prenatal Screening (NIPS) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Non-Invasive Prenatal Screening (NIPS) Revenue in 2024

3.5 Global Key Players of Non-Invasive Prenatal Screening (NIPS) Head office and Area Served

3.6 Global Key Players of Non-Invasive Prenatal Screening (NIPS), Product and Application

3.7 Global Key Players of Non-Invasive Prenatal Screening (NIPS), Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Non-Invasive Prenatal Screening (NIPS) Breakdown Data by Type

4.1 Global Non-Invasive Prenatal Screening (NIPS) Historic Market Size by Type (2020-2025)

4.2 Global Non-Invasive Prenatal Screening (NIPS) Forecasted Market Size by Type (2026-2031)

5 Non-Invasive Prenatal Screening (NIPS) Breakdown Data by Application

5.1 Global Non-Invasive Prenatal Screening (NIPS) Historic Market Size by Application (2020-2025)

5.2 Global Non-Invasive Prenatal Screening (NIPS) Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Non-Invasive Prenatal Screening (NIPS) Market Size (2020-2031)

6.2 North America Non-Invasive Prenatal Screening (NIPS) Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2020-2025)

6.4 North America Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Non-Invasive Prenatal Screening (NIPS) Market Size (2020-2031)

7.2 Europe Non-Invasive Prenatal Screening (NIPS) Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2020-2025)

7.4 Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Size (2020-2031)

8.2 Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2020-2025)

8.4 Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Non-Invasive Prenatal Screening (NIPS) Market Size (2020-2031)

9.2 Latin America Non-Invasive Prenatal Screening (NIPS) Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2020-2025)

9.4 Latin America Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size (2020-2031)

10.2 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2020-2025)

10.4 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Myriad Genetics

11.1.1 Myriad Genetics Company Details

11.1.2 Myriad Genetics Business Overview

11.1.3 Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Introduction

11.1.4 Myriad Genetics Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2020-2025)

11.1.5 Myriad Genetics Recent Development

11.2 Illumina

11.2.1 Illumina Company Details

11.2.2 Illumina Business Overview

11.2.3 Illumina Non-Invasive Prenatal Screening (NIPS) Introduction

11.2.4 Illumina Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2020-2025)

11.2.5 Illumina Recent Development

11.3 Progenity

11.3.1 Progenity Company Details

11.3.2 Progenity Business Overview

11.3.3 Progenity Non-Invasive Prenatal Screening (NIPS) Introduction

11.3.4 Progenity Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2020-2025)

11.3.5 Progenity Recent Development

11.4 Natera

11.4.1 Natera Company Details

11.4.2 Natera Business Overview

11.4.3 Natera Non-Invasive Prenatal Screening (NIPS) Introduction

11.4.4 Natera Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2020-2025)

11.4.5 Natera Recent Development

11.5 Yourgene Health

11.5.1 Yourgene Health Company Details

11.5.2 Yourgene Health Business Overview

11.5.3 Yourgene Health Non-Invasive Prenatal Screening (NIPS) Introduction

11.5.4 Yourgene Health Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2020-2025)

11.5.5 Yourgene Health Recent Development

11.6 Roche Sequencing Solutions (RSS)

11.6.1 Roche Sequencing Solutions (RSS) Company Details

11.6.2 Roche Sequencing Solutions (RSS) Business Overview

11.6.3 Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Introduction

11.6.4 Roche Sequencing Solutions (RSS) Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2020-2025)

11.6.5 Roche Sequencing Solutions (RSS) Recent Development

11.7 Eurofins LifeCodexx GmbH

11.7.1 Eurofins LifeCodexx GmbH Company Details

11.7.2 Eurofins LifeCodexx GmbH Business Overview

11.7.3 Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Introduction

11.7.4 Eurofins LifeCodexx GmbH Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2020-2025)

11.7.5 Eurofins LifeCodexx GmbH Recent Development

11.8 Labcorp

11.8.1 Labcorp Company Details

11.8.2 Labcorp Business Overview

11.8.3 Labcorp Non-Invasive Prenatal Screening (NIPS) Introduction

11.8.4 Labcorp Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2020-2025)

11.8.5 Labcorp Recent Development

11.9 PerkinElmer

11.9.1 PerkinElmer Company Details

11.9.2 PerkinElmer Business Overview

11.9.3 PerkinElmer Non-Invasive Prenatal Screening (NIPS) Introduction

11.9.4 PerkinElmer Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2020-2025)

11.9.5 PerkinElmer Recent Development

11.10 Harmony

11.10.1 Harmony Company Details

11.10.2 Harmony Business Overview

11.10.3 Harmony Non-Invasive Prenatal Screening (NIPS) Introduction

11.10.4 Harmony Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2020-2025)

11.10.5 Harmony Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Myriad Genetics

Illumina Inc

Progenity，Inc

Natera

LabCorp

PerkinElmer Inc

Harmony

Yourgene Health

Roche Sequencing Solutions (RSS)

Eurofins LifeCodexx GmbH

List of Tables

Table 1. Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Trisomy 21

Table 3. Key Players of Trisomy 18

Table 4. Key Players of Trisomy 13

Table 5. Key Players of Sex Chromosome Aneuploidies

Table 6. Key Players of Others

Table 7. Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Region (2020-2025)

Table 11. Global Non-Invasive Prenatal Screening (NIPS) Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Region (2026-2031)

Table 13. Non-Invasive Prenatal Screening (NIPS) Market Trends

Table 14. Non-Invasive Prenatal Screening (NIPS) Market Drivers

Table 15. Non-Invasive Prenatal Screening (NIPS) Market Challenges

Table 16. Non-Invasive Prenatal Screening (NIPS) Market Restraints

Table 17. Global Non-Invasive Prenatal Screening (NIPS) Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Players (2020-2025)

Table 19. Global Top Non-Invasive Prenatal Screening (NIPS) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Prenatal Screening (NIPS) as of 2024)

Table 20. Ranking of Global Top Non-Invasive Prenatal Screening (NIPS) Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Non-Invasive Prenatal Screening (NIPS) Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Non-Invasive Prenatal Screening (NIPS), Headquarters and Area Served

Table 23. Global Key Players of Non-Invasive Prenatal Screening (NIPS), Product and Application

Table 24. Global Key Players of Non-Invasive Prenatal Screening (NIPS), Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Type (2020-2025)

Table 28. Global Non-Invasive Prenatal Screening (NIPS) Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Type (2026-2031)

Table 30. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Application (2020-2025)

Table 32. Global Non-Invasive Prenatal Screening (NIPS) Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Application (2026-2031)

Table 34. North America Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2026-2031) & (US$ Million)

Table 49. Myriad Genetics Company Details

Table 50. Myriad Genetics Business Overview

Table 51. Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Product

Table 52. Myriad Genetics Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2020-2025) & (US$ Million)

Table 53. Myriad Genetics Recent Development

Table 54. Illumina Company Details

Table 55. Illumina Business Overview

Table 56. Illumina Non-Invasive Prenatal Screening (NIPS) Product

Table 57. Illumina Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2020-2025) & (US$ Million)

Table 58. Illumina Recent Development

Table 59. Progenity Company Details

Table 60. Progenity Business Overview

Table 61. Progenity Non-Invasive Prenatal Screening (NIPS) Product

Table 62. Progenity Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2020-2025) & (US$ Million)

Table 63. Progenity Recent Development

Table 64. Natera Company Details

Table 65. Natera Business Overview

Table 66. Natera Non-Invasive Prenatal Screening (NIPS) Product

Table 67. Natera Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2020-2025) & (US$ Million)

Table 68. Natera Recent Development

Table 69. Yourgene Health Company Details

Table 70. Yourgene Health Business Overview

Table 71. Yourgene Health Non-Invasive Prenatal Screening (NIPS) Product

Table 72. Yourgene Health Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2020-2025) & (US$ Million)

Table 73. Yourgene Health Recent Development

Table 74. Roche Sequencing Solutions (RSS) Company Details

Table 75. Roche Sequencing Solutions (RSS) Business Overview

Table 76. Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Product

Table 77. Roche Sequencing Solutions (RSS) Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2020-2025) & (US$ Million)

Table 78. Roche Sequencing Solutions (RSS) Recent Development

Table 79. Eurofins LifeCodexx GmbH Company Details

Table 80. Eurofins LifeCodexx GmbH Business Overview

Table 81. Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Product

Table 82. Eurofins LifeCodexx GmbH Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2020-2025) & (US$ Million)

Table 83. Eurofins LifeCodexx GmbH Recent Development

Table 84. Labcorp Company Details

Table 85. Labcorp Business Overview

Table 86. Labcorp Non-Invasive Prenatal Screening (NIPS) Product

Table 87. Labcorp Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2020-2025) & (US$ Million)

Table 88. Labcorp Recent Development

Table 89. PerkinElmer Company Details

Table 90. PerkinElmer Business Overview

Table 91. PerkinElmer Non-Invasive Prenatal Screening (NIPS) Product

Table 92. PerkinElmer Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2020-2025) & (US$ Million)

Table 93. PerkinElmer Recent Development

Table 94. Harmony Company Details

Table 95. Harmony Business Overview

Table 96. Harmony Non-Invasive Prenatal Screening (NIPS) Product

Table 97. Harmony Revenue in Non-Invasive Prenatal Screening (NIPS) Business (2020-2025) & (US$ Million)

Table 98. Harmony Recent Development

Table 99. Research Programs/Design for This Report

Table 100. Key Data Information from Secondary Sources

Table 101. Key Data Information from Primary Sources

Table 102. Authors List of This Report

List of Figures

Figure 1. Non-Invasive Prenatal Screening (NIPS) Picture

Figure 2. Global Non-Invasive Prenatal Screening (NIPS) Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Type: 2024 VS 2031

Figure 4. Trisomy 21 Features

Figure 5. Trisomy 18 Features

Figure 6. Trisomy 13 Features

Figure 7. Sex Chromosome Aneuploidies Features

Figure 8. Others Features

Figure 9. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Application: 2024 VS 2031

Figure 11. Hospital Case Studies

Figure 12. Clinic Case Studies

Figure 13. Non-Invasive Prenatal Screening (NIPS) Report Years Considered

Figure 14. Global Non-Invasive Prenatal Screening (NIPS) Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Non-Invasive Prenatal Screening (NIPS) Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Region: 2024 VS 2031

Figure 17. Global Non-Invasive Prenatal Screening (NIPS) Market Share by Players in 2024

Figure 18. Global Top Non-Invasive Prenatal Screening (NIPS) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Prenatal Screening (NIPS) as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Non-Invasive Prenatal Screening (NIPS) Revenue in 2024

Figure 20. North America Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Non-Invasive Prenatal Screening (NIPS) Market Share by Country (2020-2031)

Figure 22. United States Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Non-Invasive Prenatal Screening (NIPS) Market Share by Country (2020-2031)

Figure 26. Germany Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Non-Invasive Prenatal Screening (NIPS) Market Share by Region (2020-2031)

Figure 34. China Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Non-Invasive Prenatal Screening (NIPS) Market Share by Country (2020-2031)

Figure 42. Mexico Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Share by Country (2020-2031)

Figure 46. Turkey Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Non-Invasive Prenatal Screening (NIPS) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Myriad Genetics Revenue Growth Rate in Non-Invasive Prenatal Screening (NIPS) Business (2020-2025)

Figure 50. Illumina Revenue Growth Rate in Non-Invasive Prenatal Screening (NIPS) Business (2020-2025)

Figure 51. Progenity Revenue Growth Rate in Non-Invasive Prenatal Screening (NIPS) Business (2020-2025)

Figure 52. Natera Revenue Growth Rate in Non-Invasive Prenatal Screening (NIPS) Business (2020-2025)

Figure 53. Yourgene Health Revenue Growth Rate in Non-Invasive Prenatal Screening (NIPS) Business (2020-2025)

Figure 54. Roche Sequencing Solutions (RSS) Revenue Growth Rate in Non-Invasive Prenatal Screening (NIPS) Business (2020-2025)

Figure 55. Eurofins LifeCodexx GmbH Revenue Growth Rate in Non-Invasive Prenatal Screening (NIPS) Business (2020-2025)

Figure 56. Labcorp Revenue Growth Rate in Non-Invasive Prenatal Screening (NIPS) Business (2020-2025)

Figure 57. PerkinElmer Revenue Growth Rate in Non-Invasive Prenatal Screening (NIPS) Business (2020-2025)

Figure 58. Harmony Revenue Growth Rate in Non-Invasive Prenatal Screening (NIPS) Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Noninvasive Prenatal Testing Service Market Research Report 2025

Non Invasive Prenatal Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Non invasive Parenteral Screening Market Insights Forecast to 2030

Global Non invasive Parenteral Screening Instruments Market Insights Forecast to 2030

Global Non Invasive Prenatal Testing Devices Market Insights Forecast to 2030

Non invasive Prenatal Testing Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Non Invasive Prenatal Testing Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Non Invasive Prenatal Testing NIPT Market Research Report 2024

Global Non invasive Prenatal Paternity Testing NIPPT Market Research Report 2024

Global Non invasive Preimplantation Genetic Testing Market Research Report 2024

Global Microarray based Non Invasive Prenatal Testing Market Research Report 2024

Global Prenatal Genetic Screening Test Market Research Report 2024

Global Non Invasive Prenatal DNA Testing Service Market Research Report 2024

Global Non invasive Fetal and Maternal Monitoring Devices Market Research Report 2024

Global Noninvasive Prenatal Gene Testing Technology Market Research Report 2024

Global Non invasive Diagnosis Market Research Report 2025

Prenatal Testing and Newborn Screening Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Prenatal Genetic Screening Services Market Research Report 2025

Noninvasive Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions